Search Results for agency_names:"Health and Human Services Department"

The Administration for Children and Families (ACF) is requesting a 3-year extension for the Administration for Native Americans Project Outcome Assessment Survey. This survey aids in reporting on performance measures and fulfilling statutory requirements. ACF invites public comments and suggestions on the proposed information collection until February 12, 2025. Those interested can provide feedback via the specified online platform or email.

The Department of Health and Human Services (HHS) has updated the poverty guidelines to reflect a 1.2% increase in prices from 2019 to 2020, as measured by the Consumer Price Index. These guidelines help determine eligibility for federal programs like Medicaid. In some cases, due to adjustments in the formula, the guidelines may remain the same as the previous year despite inflation changes. The guidelines are mandated by law and are published annually by HHS, not the Office of Management and Budget (OMB), as some might mistakenly believe.

The Department of Health and Human Services (HHS), via the National Institutes of Health (NIH), has amended a regulation regarding clinical trials. This change updates the web address in the regulation concerning where to find information about submitting trial data to ClinicalTrials.gov. The new rule removes the old URL https://prsinfo.clinicaltrials.gov and replaces it with https://clinicaltrials.gov or a future site, modernizing and centralizing information access. This amendment is technical and does not add new requirements for affected parties.

The Food and Drug Administration (FDA) has issued an order permanently banning John Warrington Kosolcharoen from working with companies that have approved or pending drug product applications. This decision resulted from his felony conviction for fraudulently selling an unapproved stem cell product, ReGen, and making misleading claims about its safety and effectiveness. Mr. Kosolcharoen was given the chance to challenge the debarment but did not respond in the provided timeframe, leading to a waiver of his right to a hearing on the decision. During his debarment, any business that employs him for related services could also face penalties.

The Centers for Disease Control and Prevention (CDC), part of the Department of Health and Human Services, will hold a virtual meeting of the Community Preventive Services Task Force (CPSTF) on February 10-11, 2021. This meeting will discuss systematic reviews and topics such as Nutrition, Physical Activity, Obesity, and Health Equity/Social Determinants of Health. The public can attend the meeting by registering in advance, and there will be an opportunity for public comments during specific segments. The CPSTF, an independent panel, focuses on identifying programs that enhance public health by evaluating evidence and issuing recommendations, which are informative rather than mandatory.

The Centers for Disease Control and Prevention (CDC), part of the Department of Health and Human Services, has announced four awards to health organizations in Guinea, Indonesia, Pakistan, and Tanzania. These awards aim to boost public health efforts, including disease surveillance, outbreak response, and laboratory development, over a five-year period from 2025 to 2030. The total funding for these projects amounts to approximately $31 million, with specific allocations for each country's agency. This initiative seeks to strengthen global health readiness and the ability to respond quickly to health emergencies.

The Department of Health and Human Services (HHS) has finalized a rule updating the list of select agents and toxins that could be used as biological threats, effective January 16, 2025. The changes include removing certain Brucella species from the list, updating the nomenclature for several agents, increasing the permissible limit for a specific toxin, and designating Nipah virus as a Tier 1 select agent due to its high risk of misuse. The decision to retain or modify agents like the botulinum neurotoxin-producing species of Clostridium reflects considerations of public health, security, and regulatory compliance. These adjustments aim to align with current scientific understanding and reduce regulatory burdens while maintaining necessary security measures.

The Centers for Disease Control and Prevention (CDC) is seeking public feedback on a draft policy statement regarding biosafety for outdoor large animal studies involving the bacteria Brucella abortus and Brucella suis. This policy aims to guide the development of biosafety plans that comply with regulations set by both the CDC and the U.S. Department of Agriculture (USDA) for research on these bacteria, which pose a threat to human and animal health. The draft policy is available for review, and public comments can be submitted until March 16, 2021, through the provided methods. The policy's goal is to enhance safety protocols for studies on the diseases caused by these bacteria, which affect several animal species and can be transmitted to humans.

The Drug Enforcement Administration (DEA) and the Department of Health and Human Services (HHS) have decided to delay the start date for two rules about using telemedicine to prescribe certain medications to December 31, 2025. These rules include the "Expansion of Buprenorphine Treatment via Telemedicine Encounter," which allows practitioners to prescribe medications for opioid use disorder, and "Continuity of Care via Telemedicine for Veterans Affairs Patients," which permits Veterans Affairs practitioners to prescribe controlled substances via telemedicine under specific conditions. The delay grants additional time to address any questions or issues and follows public feedback, with some comments favoring an immediate start and others requesting a postponement.

The Centers for Disease Control and Prevention (CDC), part of the Department of Health and Human Services, is awarding around $20 million to the World Health Organization (WHO), with the total expected funding to reach approximately $100 million over five years. This funding will help CDC and WHO work together to improve the world's ability to detect, respond to, and prevent infectious diseases. The focus is on building infrastructure and preparing for disease outbreaks, using WHO's global network to support these efforts. The award period is from September 2025 to September 2030.